유한양행은 레이저티닙의 효과와 안전성을 입증한 임상 1·2상 관련 논문이 '란셋 온콜로지'에 4일 게재됐다고 밝혔다.
Yuhan Corporation announced that a paper related to Phase 1 and Phase 2 clinical trials that proved the effectiveness and safety of laser tinib was published in "Lancet Oncology" on the 4th.